Increasing Tetrahydrobiopterin in Cardiomyocytes Adversely Affects Cardiac Redox State and Mitochondrial Function Independently of Changes in NO Production by Sethumadhavan, Savitha et al.
Marquette University
e-Publications@Marquette
Physics Faculty Research and Publications Physics, Department of
4-1-2016
Increasing Tetrahydrobiopterin in Cardiomyocytes
Adversely Affects Cardiac Redox State and
Mitochondrial Function Independently of Changes
in NO Production
Savitha Sethumadhavan
Medical College of Wisconsin
Jennifer Whitsett
Medical College of Wisconsin
Brian Bennett
Marquette University, brian.bennett@marquette.edu
Irina A. Ionova
Medical College of Wisconsin
Galen M. Pieper
Medical College of Wisconsin
See next page for additional authors
Accepted version. Free Radical Biology and Medicinee, Vol. 93 (April 2016): 1-11. DOI. © 2016
Elsevier. Used with permission.
NOTICE: this is the author’s version of a work that was accepted for publication in Free Radical
Biology and Medicine. Changes resulting from the publishing process, such as peer review, editing,
corrections, structural formatting, and other quality control mechanisms may not be reflected in this
document. Changes may have been made to this work since it was submitted for publication. A
definitive version was subsequently published in Free Radical Biology and Medicine, VOL. 93, April
2016, DOI.
Authors
Savitha Sethumadhavan, Jennifer Whitsett, Brian Bennett, Irina A. Ionova, Galen M. Pieper, and Jeannette
Vasquez-Vivar
This article is available at e-Publications@Marquette: https://epublications.marquette.edu/physics_fac/117
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Free Radical Biology and Medicine, Vol 93 (2016, April): pg. 1-11. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
1 
 
 
 
Increasing Tetrahydrobiopterin in 
Cardiomyocytes Adversely Affects 
Cardiac Redox State and 
Mitochondrial Function 
Independently of Changes in NO 
Production 
 
Savitha Sethumadhavan 
Department of Biophysics, Medical College of Wisconsin 
Milwaukee, WI 
Jennifer Whitsett 
Department of Biophysics, Medical College of Wisconsin 
Milwaukee, WI 
Brian Bennett 
Department of Biophysics, Medical College of Wisconsin 
Department of Physics, Marquette University, Milwaukee, WI 
Irina A. Ionova 
Department of Surgery Medicine, Medical College of Wisconsin 
Milwaukee, WI  
Galen M. Pieper 
Department of Surgery Medicine, Medical College of Wisconsin 
Milwaukee, WI 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Free Radical Biology and Medicine, Vol 93 (2016, April): pg. 1-11. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
2 
 
Jeannette Vasquez-Vivar 
Department of Biophysics, Medical College of Wisconsin 
Milwaukee, WI 
 
 
 
Abstract: Tetrahydrobiopterin (BH4) represents a potential strategy for the 
treatment of cardiac remodeling, fibrosis and/or diastolic dysfunction. The 
effects of oral treatment with BH4 (Sapropterin™ or Kuvan™) are however 
dose-limiting with high dose negating functional improvements. 
Cardiomyocyte-specific overexpression of GTP cyclohydrolase I (mGCH) 
increases BH4 several-fold in the heart. Using this model, we aimed to 
establish the cardiomyocyte-specific responses to high levels of BH4. 
Quantification of BH4 and BH2 in mGCH transgenic hearts showed age-based 
variations in BH4:BH2 ratios. Hearts of mice (<6 months) have lower BH4:BH2 
ratios than hearts of older mice while both GTPCH activity and tissue 
ascorbate levels were higher in hearts of young than older mice. No evident 
changes in nitric oxide (NO) production assessed by nitrite and endogenous 
iron–nitrosyl complexes were detected in any of the age groups. Increased 
BH4 production in cardiomyocytes resulted in a significant loss of 
mitochondrial function. Diminished oxygen consumption and reserve capacity 
was verified in mitochondria isolated from hearts of 12-month old compared 
to 3-month old mice, even though at 12 months an improved BH4:BH2 ratio is 
established. Accumulation of 4-hydroxynonenal (4-HNE) and decreased 
glutathione levels were found in the mGCH hearts and isolated mitochondria. 
Taken together, our results indicate that the ratio of BH4:BH2 does not predict 
changes in neither NO levels nor cellular redox state in the heart. The BH4 
oxidation essentially limits the capacity of cardiomyocytes to reduce oxidant 
stress. Cardiomyocyte with chronically high levels of BH4 show a significant 
decline in redox state and mitochondrial function. 
Graphical abstract 
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1. Introduction 
Tetrahydrobiopterin (BH4) is an essential cofactor for the 
synthesis of nitric oxide (NO) by all three nitric oxide synthases (NOS) 
[1], [2] and [3]. In the heart, basal NO levels produced by 
constitutively expressed NOS are attributed with the maintenance of 
essential cardiac functions such as calcium homeostasis [4] and [5], 
contractility [6], defense against stress conditions resulting from 
ischemia/reperfusion [7] and [8] and hypoxia [9]. Development of 
therapies to increase cardiac BH4 levels are based on the notion that 
increased BH4 levels will improve NO-dependent responses. Also 
increasing BH4 levels in the heart prevents oxidant injury from 
superoxide generated from NOS via an uncoupling mechanism 
[10] and [11]. 
Cellular levels of BH4 in cardiomyocytes and endothelial cells is 
effectively increased several fold by upregulating the expression of 
GTP cyclohydrolase I (GTPCH) [12]. In the de novo biosynthetic 
pathway GTP is used as a substrate and it is converted to BH4 by the 
concerted action of three enzymes: GTPCH, pyruvoyltetrahydro-pterin 
synthase (PTPS) and sepiapterin reductase (SR). The GTPCH catalyzes 
the first committed step of the pathway. Since increase in GTPCH 
expression and activity in several cell types is followed by an increase 
in intracellular BH4, this enzyme is considered rate-limiting in BH4 
synthesis [13]. The salvage pathway uses as substrate 7,8-
dihydrobiopterin (BH2), the two electron oxidation product of BH4, that 
is reduced to BH4 by dihydrofolate reductase (DHFR) at the expense of 
NADPH. The efficiency of the salvage pathway is highly dependent on 
cell- and tissue-specific variations of DHFR and folate metabolism 
[14] and [15]. In adult cardiomyocytes DHFR protein expression is not 
detected [16]. 
Previously, it has been shown that neonatal cardiomyocytes 
upregulate GTPCH in response to increase release of cytokines such as 
IL-1, IFN, and TNF [17]. The concept has been developed that a co-
upregulation of both GTPCH/BH4 and iNOS pathways in the heart may 
explain several of the damaging effects of cytokines [18]. Adult 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Free Radical Biology and Medicine, Vol 93 (2016, April): pg. 1-11. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
4 
 
cardiomyocytes stimulated with cytokines, lipopolysaccharides or 
combination of both however demonstrated weakened responses in 
terms of upregulated GTPCH expression and BH4 production 
[16] and [19]. This observation raised the possibility that 
cardiomyocytes do not mediate NO-regulated responses to cytokines 
in the adult heart, and that increased GTPCH/NO are better explained 
by stimulation of other cell types in the heart and/or due to infiltrating 
inflammatory cells [20] and [21]. To clarify this idea, we generated a 
mouse model expressing GTPCH gene in a cardiomyocyte-specific 
manner (mGCH) [22]. Analysis of the transgenic mouse heart 
confirmed an increased expression of GTPCH protein together with 
high BH4 production. Notably, this model showed that increased BH4 
production protected the heart against acute allograft rejection as 
shown by decreased histological rejection, cardiac injury and cell 
death. These responses however were not linked to NO surge but to 
changes in IL-2 and stromal derived factor-1 expression levels [22]. 
Another model for the cardioprotective activity of cardiomyocyte-
targeted BH4 was indicated in a hyperglycemic model of ischemic 
preconditioning (IPC) [23]. In this experimental model, BH4 reverted 
the negative effects of hyperglycemia on myocardial and mitochondrial 
protection by IPC. These effects were in part linked to an improved 
mitochondrial calcium response that is otherwise altered in 
hyperglycemic conditions. 
Previous studies by others addressing the potential use of BH4 in 
cardiac disease incorporated the use of exogenous BH4[24] and [25]. 
Using a mouse model of pressure overload-induced cardiac 
hyperthrophy, it was shown that BH4 treatments reduced maladaptive 
cardiac remodeling [25]. BH4 effects however presented dose-
dependent limitations, with high doses given orally showing no 
benefits. This effect was linked to the decreased ability of BH4 to 
inhibit superoxide generation. Since orally-administered BH4 targets 
different cell types in the heart, it is difficult to specifically attribute 
these responses to cardiomyocytes. Moreover, our understanding of 
the stability of BH4 and degree of NOS-activation elicited when present 
in high concentrations as seen in cardiomyocytes treatment is limited. 
This study tested the hypothesis that the predominant mechanism 
limiting BH4 activity in cardiomyocytes is not due to changes in NO 
production. Studies were conducted in mice with cardiomyocyte-
specific overexpression of GTPCH in vivo and examining temporal 
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variations in BH4 fluxes and BH4:BH2 ratios, cardiac NO production and 
its impact on mitochondrial bioenergetics. 
2. Materials and methods 
2.1. Animals 
All experiments conducted on animals in this study were 
performed in compliance with the National Institutes of Health Guide 
for the Care and Use of Laboratory Animals (NIH Pub. No. 85-23). 
Protocols and procedures were approved by the Institutional Animal 
Care and Use Committee of the Medical College of Wisconsin. 
2.2. Biochemical methods 
2.2.1. Quantification of BH4, BH2 and ascorbate using HPLC with 
electrochemical detection 
Left ventricular tissue was homogenized in cold 50 mM 
phosphate buffer pH 2.6 with 0.1 mM diethylenetriaminepentaacetic 
acid (DTPA) and 1 mM dithiothreitol (DTE), freshly added. Samples 
were spun down at 15,700×g for 20 min. The pellets were discarded 
and supernatant was transferred to Amicon 10K (Millipore, Bedford, 
MA) filters for deproteinization. An aliquot of the supernatant was also 
taken for protein quantification. The eluents from 45-min 
centrifugation 15,000×g were loaded onto a Synergi Polar RP column 
(250×4.6 mm, Phenomenex, Torrance, CA) and components were 
eluted using a flow of 0.7 ml/min of 25 mM phosphate buffer pH 2.6. 
Compounds were detected using a CoulArray™ detector (ESA 
Biosciences) equipped with a 4-sensor cell operating at 0, 150, 280 
and 365 mV, as described [26]. Standards were used for quantification 
and concentrations were normalized to protein content of the samples. 
2.2.2. Enzymes activity 
A GTPCH enzyme activity was determined as previously 
described [27], with some modifications. Briefly, heart and liver 
tissues were homogenized in 50 mM Tris–HCl, pH 7.4 buffer, 
containing 1 mM MgCl2, 0.1 M KCl, 1 mM ethylenediaminetetraacetate 
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(EDTA), 1 mM ethylene glycol tetraacetic acid (EGTA), freshly-added 
0.2 mmol/L phenylmethylsulfonyl fluoride, and 1.0 μg/ml each of 
aprotinin, leupeptin, and pepstatin. Supernatants obtained by 
centrifugation of samples for 15 min at 4 °C, at 12,000×g were 
transferred to a pre-chilled clean tube and centrifuged for additional 
45 min at 15,000×g. A 300 μL aliquot of the supernatant was added to 
300 μL of reaction buffer (50 mM Tris–HCl, pH 7.5, containing 0.3 M 
KCl and 2.5 mM EDTA) containing 2.5 mM freshly added Guanosine-5ʹ-
triphosphate (GTP), 1 mg/ml bovine serum albumin (BSA) and 2.5 mM 
dithiothreitol (DTT). The reaction was stopped by adding 3 µL 5 N HCl 
at 0, 1 h and 2 h time points. The oxidation of the reaction product 
7,8-dihydroneopterin triphosphate to neopterin triphosphate was 
performed at room temperature by adding 15 μL of oxidizing solution 
(0.04 g% iodine and 0.08 g% potassium iodide in 1 N HCl) and 
incubated for 60 min in the dark. The excess of unreacted I2/KI 
reagent was removed by the addition of 2 µL 20% ascorbic acid 
solution. To remove phosphate groups from neopterin triphosphate, 
samples pH were adjusted to 9–10 and incubated with 5U alkaline 
phosphatase solution (Sigma) at 37 °C for 60 min. Samples were 
cleaned by filtration through filters (10 K m.w.c.o Millipore, Bedford, 
MA), and loaded onto a Kinetex C18 column (100 mm×4.6 mm 
2.6 μm, Phenomenex) and eluted with 0.05% TFA 0.7 ml/min. D-
Neopterin was detected by fluorescence using an excitation of 350 nm 
and an emission of 440 nm. Standards were used for quantification 
and concentrations were normalized to protein content of the samples. 
2.2.3. Aconitase 
Freshly isolated hearts were washed in ice-cold DPBS and then 
homogenized in freshly prepared 50 mM Tris–HCl buffer containing 
0.1 mM DTPA and 5 mM citrate. Samples were centrifuged 800×g and 
the supernatant transferred to a fresh ice-water cold tube, which was 
subsequently centrifuged at 10,000×g for 10 min, all spins were 
performed at 4 °C. The supernatants from 10,000×g spin were 
collected (cytosolic fraction) and the pellet (mitochondrial fraction) was 
dissolved in 200 µl homogenization buffer containing 5 mM citrate. 
Protein content of the fractions was determined by bicinchoninic acid 
assay. Proteins were diluted at a concentration of 5 mg/ml and 
assayed for activity using 50 mM Tris–HCl buffer pH 8.0 containing 
20 mM DL-isocitrate and 0.1% triton x-100 at 240 nm for 3 min at 
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room temperature. Initial rates of enzyme activity were measured 
from kinetic curves and concentrations calculated using an extinction 
coefficient of 3.6 mM−1 cm−1[28]. 
2.2.4. Reduced and oxidized glutathione analysis by HPLC using 
a boron-doped diamond electrode (BDD) 
Left ventricle tissue samples were homogenized in cold 25 mM 
phosphate buffer pH 2.6 containing 0.1% triton X-100. Following 
centrifugation at 15,000×g for 10 min to remove cell debris, an aliquot 
of supernatants were deproteinized by acid precipitation using 1:1 
volume metaphosphoric acid 10% for 1 h on ice and another for 
protein measurement. Supernatants obtained from centrifugation at 
15,000×g for 45 min of acid precipitation were loaded onto a Synergi-
Hydro column (25-×4.6 mm, Phenomenex, Torrance, CA) equilibrated 
with 25 mM phosphate buffer containing 1.4 mM 1-octanesulfonic acid, 
6% v/v acetonitrile, pH 2.6 and eluted at a flow of 0.5 ml/min. The 
system consisted of an ESA automated injection system, an ESA 582 
pump, and amperometric cell (5040) with a BDD working electrode 
operating at an applied voltage of 1500 mV [29]. GSH and GSSG 
standards were used for quantification and concentrations were 
normalized to protein content. 
2.2.5. Quantification of neurotransmitters using HPLC with 
electrochemical detection 
Left ventricular tissue was homogenized in 0.1 N hydrochloric 
acid and centrifuged at 22,382×g for 10 min. An aliquot of the 
supernatant was removed for protein assay and the remaining was 
incubated with 0.1 M perchloric acid for 30 min on ice following 
centrifugation at 30,113×g for 15 min. Neurotransmitters in the 
clarified supernatant were measured by HPLC with electrochemical 
detection using an analytical column synergy Polar RP (Phenomenex, 
Torrance, CA, USA, 4.6×250.0 mm) eluted with 0.075 M sodium 
dihydrogenphosphate, 0.75 mM triethylamine, 1.5 mM sodium 
octanesulfonate, 10% acetonitrile pH 3.0 at flow rate of 1.0 ml/min 
[30]. The system consisted of an ESA automated injection system, an 
ESA 582 pump, 4-sensor cell operating at an applied potential of 0, 
220, 300 and 350 mV and controlled by CoulArray detector (ESA, 
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Chelmsford, MA, USA). Dopamine, 3,4-dihydroxyphenylacetic acid, 
homovanillic acid (HVA), serotonin (5-HT), norepinephrine, 
epinephrine (10–100 ng/ml) were used as standards. Contents of 
neurotransmitters were calculated as ng/mg protein. 
2.2.6. Cardiac mitochondria isolation 
Hearts from 12-week, and 12-month old mice were processed 
immediately after excision for mitochondrial isolation at 4 °C. 
Mitochondria isolation was performed using standard differential 
centrifugation techniques. Briefly, heart tissue was collected and 
homogenized in mitochondria isolation buffer: 70 mM Sucrose, 
210 mM mannitol, 5 mM HEPES, 1 mM EGTA and 0.5% fatty acid-free 
BSA, pH 7.2. Homogenates were centrifuged at 700×g for 10 min at 
4 °C (Sorvall High speed, SA600 rotor). The supernatant was 
transferred to a cold, clean tube (Nalgene) and subjected to a high-
speed centrifugation (10,000×g, 10 min, 4 °C). The final supernatant 
was discarded and the mitochondrial pellet washed twice with the 
isolation buffer. Finally, the pellets were resuspended in mitochondria 
assay buffer: 70 mM Sucrose, 220 mM mannitol, 10 mM KH2PO4, 5 mM 
MgCl2, 2 mM HEPES, 1 mM EGTA and 0.2% fatty acid-free BSA, pH 7.2 
[31]. Mitochondrial preparation was used immediately for respiration 
measurements or stored at −80 °C for immunoblot. 
2.2.7. Mitochondrial respiration measurements using XF96 
analyzer 
Respiration was carried out in isolated mitochondria using 
Extracellular Flux Analyzer (XF) 96-well format (Seahorse Bioscience, 
North Billerica, MA). Isolated mitochondria (3 μg in 140 μL of assay 
buffer) in the presence of substrates (5 mM glutamate and 5 mM 
malate) were loaded onto a 96-well polystyrene microplate and 
transferred to a centrifuge equipped with a swinging bucket microplate 
adaptor and spun at 2000×g for 10 min at 4 °C. Following 
centrifugation, the plates were warmed at 37 °C for 10 min and 
transferred to the XF 96 analyzer [32]. Respiration was initially 
measured in basal conditions (State 2). State 3 respiration was 
initiated by injected ADP (1 mM); oligomycin- induced state 4 was 
carried out by injecting oligomycin (2.5 μg/ml); uncoupled state 3 
respiration after the addition of FCCP (0.75 μM) and mitochondrial 
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respiration was inhibited following the addition of antimycin (4 μM) 
respectively. Oxygen consumption rate (OCR) was measured using 
mix/measure/mix time cycle of 0.5 min/3 min/1 min, respectively. 
2.2.8. Low-temperature electron paramagnetic resonance (EPR) 
analysis of mitochondrial protein complexes and iron–nitrosyl 
content in cardiac tissue 
Freshly-excised hearts were quickly loaded on a 4 mm quartz 
EPR tubes (Wilmad Glass, Buena, NJ, USA) and samples snap frozen in 
liquid nitrogen. Samples were analyzed using a X-band EPR 
spectrometer Bruker E500 ELEXYS with 100 kHz field modulation, 
equipped with an Oxford Instrument ESR-9 helium flow cryostat and a 
DM-0101 cavity. Spectrometer conditions were as follows: microwave 
frequency, 9.635 GHz; modulation frequency, 100 kHz; modulation 
amplitude, 10 G; receiver gain, 85 dB; time constant, 0.01 s; 
conversion time, 0.08 s; and sweep time, 83.9 s. EPR spectra were 
obtained over the temperature range 12–40 K using an incident 
microwave power of 0.25 mW and 5  mW, respectively. 
2.3. Statistical analysis 
Results are reported as mean±S.E.M. Comparisons between two 
groups were performed with paired Student’s t tests. P<0.05 was 
considered statistically significant. 
3. Results 
3.1. Profiling of BH4 changes in mice hearts over-
expressing GTPCH 
Enhanced GTPCH activity in transgenic hearts (mGCH) was 
previously shown by specific detection of high GTPCH protein 
expression and increased BH4 levels that were several-fold higher than 
those detected in hearts from wild type mice [22]. To assess the 
persistence of this increase, we analyzed BH4 in left ventricle (LV) in 
hearts from normal growing mGCH at different ages and compared 
these changes with those found in hearts from age-matched, wild type 
animals. In wild type C57Bl6 hearts, non-significant variations in BH4 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Free Radical Biology and Medicine, Vol 93 (2016, April): pg. 1-11. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
10 
 
were registered with age with an average concentration of 
5.35±1.88 pmol/mg protein (n=15). In the transgenic hearts, a 
continuous normalized increase in BH4 concentration was detected 
between 2 and 6 months of age (Fig. 1A). This rise continued until 
about 6 months of age. After this period, BH4 concentrations reached a 
steady state as verified between 7 and 12 months old (Fig. 1B). 
Variable concentrations of the oxidized metabolite 7,8-dihydrobiopterin 
(BH2) levels were also found. A greater accumulation of BH2 than BH4 
in hearts <6 months age than >6 months was demonstrated (Fig. 1A 
and B). The calculated fluctuation of BH4:BH2 ratio with age indicated 
that effective accumulation of BH2 is more prominent in the young 
hearts (Fig. 1C). Cardiac tissue is rich in reduced ascorbate (AH−), and 
it is concomitantly detected with BH4 and BH2 during HPLC analysis. 
The quantification of AH− levels in the heart from transgenic mice 
showed that AH− concentration declined with age (32.9±12 to 
20.1±5.1 nmol/mg protein), yet it remained in an excess of ~100 fold 
with respect to BH4 (Fig. 1D). 
 
Fig. 1. Cardiac 6R-tetrahydrobiopterin (BH4), 7,8-dihydrobiopterin (BH2) and 
ascorbate HPLC-ECD analysis in cardiomyocyte-specific transgenic (Tg) hearts 
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overexpressing GTPCH (mGCH). (A and B) Quantification of BH4, 7,8-dihydropterin 
(BH2) in left ventricular tissue of increasing age. (C) Calculated ratio of BH4 to BH2 in 
left ventricular heart tissue from hearts at different ages. (D) Ratio of reduced 
ascorbate to BH4 in left ventricular tissue from mGCH animals. Assays of BH4, BH2 and 
ascorbate were performed by HPLC-ECD as described in Section 2. WT, indicate 
cardiac tissue from C57Bl6 mice hearts. All concentrations were normalized to protein 
content and results are presented as mean±S.D. (n>5) samples per group. 
(#,**)p<0.05. 
3.2. GTPH activity in transgenic hearts 
To better understand the relationship between changes in 
GTPCH enzyme activity and BH4 levels with age, direct activity assay 
measuring the GTP conversion to 7,8-dihydroneopterin was performed. 
It was shown that GTPCH activity in 3-month old mouse hearts was 
higher than enzyme activity detected in 11-month-old transgenic 
mouse hearts. GTPCH activity in 3- and 11-month old hearts was 
sensitive to inhibition by DAHP, a GTPCH inhibitor (Fig. 2A). Biopterin, 
the final degradation product of BH4 accumulated in cardiac tissue was 
also decreased in 11-month compared to 3-month heart tissue (Fig. 
2B). This change in enzyme activity corresponds with a decrease in 
GTPCH protein expression levels in the heart (Supplementary Fig. 1). 
The age-dependent decrease in GTPCH activity was specific to heart 
tissue, as compared to the liver. The GTCPH activity in the liver (Fig. 
2C) was ~20-fold lower than hearts. This difference was also mirrored 
by the low level of biopterin in liver relative to those found in the heart 
(Fig. 2D). In the liver however, GTPCH enzyme activity in 3-month and 
11-month old mice was not significantly different. Together these data 
indicated that early variations in cardiac BH4 levels are not explained 
by deficient GTPCH activity in transgenic heart and that a decreased 
GTPCH activity with age is not directly mirrored in BH4:BH2 ratio 
changes. 
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Fig. 2. GTP cyclohydrolase (GTPCH) activity in transgenic hearts and liver. 
Enzyme activity was measured in tissue homogenates (A) heart (C) liver by 
analyzing the rate of hydrolysis of GTP to 7,8-dihydroneopterin phosphate as 
described in Section 2. The oxidation product neopterin was quantified by 
HPLC with fluorescence detection. Biopterin, the BH4 and BH2 metabolite in 
tissue homogenates (B) heart and (D) liver was directly measured by 
analyzing supernatant of tissue homogenates clarified by filtration. All values 
were normalized by protein content in tissue homogenates. Results are 
presented as mean±SD (n=4). (**, ¶) p<0.05, (#, ##) p<0.02. 
3.3. High cardiac BH4 does no increase cardiac NOx 
levels nor neurotransmitters production 
To establish the functional significance of changes in BH4:BH2 
content in GTPCH-overexpressing cardiomyocytes, we verified enzyme 
activity of enzymes requiring BH4 as cofactor. Specifically NO 
metabolites and neurotransmitters were analyzed as products of these 
enzyme pathways. It was found that neither wild type nor GTPCH 
transgenic hearts have significant changes in NO metabolites and that 
concentrations are very similar between these two groups (Fig. 3). 
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Cardiac neurotransmitters were also unaltered by increased GTPCH 
expression and activity (Fig. 4B–D). This indicated that changes in the 
BH4:BH2 ratio due to specific GTPCH overexpression in the 
cardiomyocytes does not alter neurochemical inputs in the heart. 
 
Fig. 3. Nitrite analysis in cardiac tissue from C57Bl6 hearts (wild type) and 
cardiomyocyte targeted GTPCH transgenic hearts (mGCH). Samples from cardiac 
tissue were analyzed using nitric oxide analyzer (NOA) with chemiluminescence 
detection. Results represent the mean±SD (n=6). No differences were established. 
 
Fig. 4. Neurotransmitter levels in cardiac tissue of C57Bl6 hearts (wild type) and 
cardiomyocyte targeted GTPCH transgenic hearts (mGCH). HPLC-ECD analysis of 
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dopamine, norepinephrine, epinephrine and 5-hydroxytryptamine in cardiac tissues 
were analyzed as described in Section 2. Results are expressed as mean±S.D. (n=4). 
No differences were established. 
3.4. EPR analysis of NO-surrogate markers in GTPCH 
overexpressing hearts 
As cardiac NOx content is susceptible to influence of dietary and 
other physiological factors that can mask changes in NO production as 
measured by NOx levels, wild type and GTPCH transgenic hearts were 
examined at low-temperature EPR for the presence of endogenous 
markers of increased production of NO. Specifically, changes in nitrosyl 
heme and mitochondrial aconitase (g~2.02) and dinitrosyl–iron–dithiol 
complex (g~2.04) were investigated [33], [34] and [35]. Low-helium 
temperature (40 K) EPR analysis of standard samples of nitrosyl-heme 
hemoglobin–NO complexes shows two species due to Fe–NO complex 
of heme-iron in the 5 coordinated and 6 coordinated state respectively 
(Fig. 5A) [33] and [34]. The 5-coordinated Hb–NO complex shows 
rhombic EPR signal with a characteristic triplet signal at g~2.014 due 
to porphyrin (Fe)–NO. The spectrum of the 6-coordinated form of 
porphyrin(Fe)–NO species is dominated by rhombic signal and it is one 
of the complexes detected in cardiac tissue with relatively low NO 
fluxes. We analyzed freshly excised tissue that was snap frozen in 
liquid nitrogen and found no evidences for porphyrin (Fe)–NO in any of 
the tissue analyzed ( Fig. 5B). The samples analyzed were from 
transgenic mice of 2 (a), 4 (b) and 6 (c) months of age and tissue 
from 3 months of age wild type (d). The main signal in the recorded 
spectra at 40 K is consistent with the presence of ubisemiquinone 
radical at g~2 and iron–sulfur (Fe–S) complex g~1.94 which are 
characteristic EPR signal found in heart samples. No consistent 
differences in the region g~2.04 were detected. 
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Fig. 5. Low-temperature EPR analysis (40 K) of cardiac tissue form C57Bl6 hearts 
(wild type) and cardiomyocyte targeted GTPCH transgenic hearts (mGCH): (A) 
standard samples of 5- and 6-coordinated complexes of hemoglobin (Fe–NO). (B) 
mGCH and wild type cardiac samples: (a) mGCH-4 months; (b) mGCH-6 months; (c) 
mGCH-2 months; and (d) C57Bl6-3 months. Single samples were inserted in quartz 
EPR tubes and snap frozen in liquid nitrogen as soon as isolated. Instrument setting 
are as described in Section 2. (▼) Ubiquinone radical; (Fe–S) mitochondrial 2FeS2 
centers. 
At temperatures of 12 K the EPR analysis of same tissue 
samples analyzed before showed a low-magnetic field signal at g~6.0 
due to high spin (HS) (S=5/2) porphyrin–Fe(III) species (Fig. 6) [36]. 
The signal intensity of this species changed with age with a high 
intensity in hearts from 2-month old mice and decreased in samples 
from older mice. In wild type control samples, the ferric HS signal was 
also present but at a lower intensity. A low intensity signal in the 
region g~4.3 (ferric iron) [37] was common to all samples. 
Multicomponent EPR signals in the g~2 region were also discernible. 
The signals detected at g~2 are typical of iron-protein containing 
mitochondrial clusters for complex I, II and III showing equivalent 
contribution to the EPR spectra. The detected variations in porphyrin-
(FeIII) (HS) content in the transgenic hearts however suggests that 
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oxidation–reduction reactions occur in <6-month old tissue samples 
which may explain variations in the BH4/BH2 in this age-group. 
 
Fig. 6. Low-temperature EPR analysis (12 K) of cardiac tissue from C57Bl6 hearts 
(wild type) and GTPCH transgenic cardiomyocyte: (A) wide field EPR scanning of wild 
type and mGCH-samples (ages: 2, 4, and 6 months) revealed a high spin Fe(III)-
porphyrin signal g~6 that shows a higher intensity in young transgenic than wild type 
hearts (inset: zoom of g~6 signal). (B) EPR signal of cardiac mitochondrial complexes 
showing non-significant variations between transgenic than wild type tissue. EPR 
spectra display the sum of the various redox centers of protein complexes such as: 
(◊) cI-N4 4Fe4S, (○) cI-N2 4Fe4S, (▼) aconitase 3Fe4S, cI-N1b 2Fe2S, cII-S1 2Fe2S, 
cII-S3 3Fe4S, (◘) ubiquinone radical, (●) cI-N1b 2Fe2S, cII-S1 2Fe2S, (∇) cII-S1 
2Fe2S, cI-N1b 2Fe2S, (◊) cI-N4 4Fe4S, Rieske 2Fe2S, and (■) cI-N3 4Fe4S. 
3.5. Effects of increased cardiomyocyte BH4 on 
mitochondrial levels and function 
Altered BH4:BH2 content has been associated with changes in 
oxidant production in cardiac diseases such as heart failure, 
myocardial hypertrophy. Increased oxidant levels may contribute to 
changes in mitochondrial function. To investigate changes in 
mitochondrial functional states mGTPCH hearts, oxygen consumption 
rates (OCR) were measured in isolated mitochondria from 3- and 12-
month old GTPCH transgenic mice. The assays were performed 
simultaneously with freshly isolated mitochondria using a high-
throughput XF-assay as described in Section 2. The optimized 
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mitochondrial protein loading on the experimental well (Fig. 7A) was 
adjusted to reach State 2 OCR ~100 pmol/min per well. State 3 
respiration was stimulated by addition of ADP, and maximal respiration 
rates were stimulated with mitochondrial uncoupler, FCCP. 
Mitochondrial preparations obtained from 3-month animals showed a 
higher ADP-stimulated respiration rate compared to mitochondria 
isolated from wild type animals (C57Bl6). In contrast, cardiac 
mitochondrial preparations from 12-month old GTPCH transgenic 
animals showed a significant slower State-2 respiration rate compared 
to C57Bl6 (Fig. 7B). The same relationships were determined for 
uncoupled mitochondrial OCR, mitochondrial from 3-month old mouse 
hearts showing a better performance than wild type but a lower 
performance at 12 months of age. The decreased rate of respiration in 
mitochondria of 12-month old mouse hearts is unlikely explained by 
variation in respiratory complexes content since the amount of 
mitochondrial complexes as shown in low-temperature EPR analysis 
remain at comparable levels. Also, EPR data and NOx data do not 
support the notion of increased NO as a mediator of the observed 
decline in respiration rates. 
 
Fig. 7. Bioenergetics characterization of isolated cardiac mitochondria from C57Bl6 
(WT) and cardiomyocyte-targeted GTPCH transgenic hearts (Tg): (A) isolated 
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mitochondria (3 µg) attached to the 96-well plate (Seahorse) used for analysis; (B) 
mitochondrial oxygen consumption of 3-month old WT-mitochondria (red traces), 
MGCH-Tg (green traces) before (State 2) or after stimulation state-3 respiration with 
ADP (1 mM), and followed by inhibition of ATP-dependent oxygen consumption with 
complex V inhibitor oligomycin (2.5 µg/ml). Maximal oxygen consumption capacity 
was assessed by addition of mitochondrial uncoupler FCCP (0.75 µM) (state 3 
uncoupled) and complete inhibition of oxygen consumption was tested with antimycin 
A (4 µM) (lower panel); (C) as (B) but mitochondria were isolated from 12-month old 
mice. (D) Quantification of State 3 respiration stimulated by ADP in mitochondria from 
wild type and Tg hearts 3-month and 12-month old; (E) same as (D) except the state 
3 uncoupled stimulated by FCCP. Results are represented as mean±S.D. of triplicate 
experiments. (***) p<0.05. 
Mitochondrial respiration is sensitive to oxidant and electrophile 
molecules [38] and [39]. In cardiomyocytes, mitochondria appear to 
be a preferred target of lipid electrophiles. Whether cardiomyocytes 
with increased GTPCH activity exhibit high levels of 4-hydroxynonenal 
(4-HNE) was examined by immunotechniques. As shown in Fig. 8 
immunohistological analysis of left ventricular cardiac tissue 
demonstrated that 4-HNE-staining is low in both young (~2 months) 
wild type and GTPCH transgenic mice while hearts from old (>10 
months) mGTPCH showed a significant higher staining score (Fig. 8B). 
Also increased 4-HNE specifically associated with mitochondrial protein 
fraction was found in isolated mitochondria from mGCH hearts but not 
wild type (C57BL6) as young as 3 months of age. Collectively, these 
data indicated that increased GTPCH activity in cardiomyocytes 
increases 4-HNE which via post-translational modification of 
mitochondrial proteins could reduce mitochondrial function with age. 
Analysis of the left ventricular tissue by HPLC demonstrated that 
GTPCH transgenic hearts have a significant lower amount of reduced 
glutathione (Fig. 8D) and a decreased cytosolic aconitase activity 
(Table I, Supplement) indicating that supra-physiological BH4 levels in 
the heart promote oxidant damage. 
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Fig. 8. Accumulation of reactive lipid species and reduced glutathione depletion in 
GTPCH transgenic hearts: (A) low levels of positive staining for 4-HNE in 
cardiomyocytes of young wild type and GTPCH transgenic hearts (Top panels A and 
B); 4-HNE positive staining is higher in old GTPCH transgenic than wild type hearts 
(Bottom panels C and D); (B) analysis of 4-HNE immunostaining score in wild type 
(WT) young (3 months) and old (12 months) and age-matched GTPCH transgenic (Tg) 
hearts; results are representative of at least 3 different samples. (***) p<0.05 and 
(***(***)) p<0.01. (C) Western blotting of 4-HNE-modified proteins from isolated 
mitochondria from 2-month old and 4-month old hearts; (D) cardiac levels of reduced 
glutathione in C57Bl6 (wild type, WT) and GTPCH transgenic (Tg) hearts analyzed 
directly by HPLC-ECD. Results are the mean±S.D. (n=3 each group age); (**) 
p<0.05. 
4. Discussion 
The major findings in this study are that targeted expression of 
GTPCH in cardiomyocytes results in a bi-phasic variation of BH4:BH2 
ratios instigating an overall worsening of cardiac myocyte redox status 
and impaired mitochondrial respiratory capacity with age. In our 
previous studies, we found a significant increase in BH4 and its 
metabolites in the heart, reaching a total of about 100-fold higher 
levels than those found in wild type heart. This accumulation did not 
alter plasma biopterin levels [22] and, as shown in this study, it did 
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not alter endogenous liver concentrations either indicating that 
increased GTPCH expression resulting in increased levels of BH4 has 
tissue-specific activity. Here we confirmed that increasing 
cardiomyocyte GTPCH results in an incremental accumulation in both 
BH4 and BH2 in the heart. Similar results have been recently described 
for a newly generated cardiac GTPCH transgenic mouse model that 
expresses a lower level of GTPCH activity [40]. Thus, increased BH2 
conversion is likely regulated by endogenous factors rather than by 
only GTPCH activity levels. 
We showed that the variation in cardiomyocyte BH4 
concentrations with age is inversely related to GTPCH enzyme activity. 
Taking into account that both BH4 and BH2 accumulated in the tissue, 
it appears that an effective cardiac surge of the total level (BH4+BH2) 
occurs at about 4 months of age to reach steady state level thereafter. 
The accumulation of BH2 in the cardiomyocyte was understandable 
since adult cardiomyocytes, unlike neonatal or embryonic 
cardiomyocytes, are deficient in DHFR [16], the enzyme that catalyzes 
the reduction of BH2 to BH4 at the expenses of NADPH. The fact that a 
more prominent accumulation of BH2 with respect to BH4 is found in 
young (e.g. 3 months) hearts than older hearts (11 months), suggests 
that an effective BH2 distribution to other cells with DHFR activity 
occurs when high intracellular BH2 concentrations in the cardiomyocyte 
have been reached. The consequences of enhanced distribution of BH2 
to other cells types is that BH2 is reduced back to BH4 in those non-
cardiomyocyte cells. One possible cell recipient of BH2 is endothelial 
cell which can reduce BH2 back to BH4 when large intracellular BH2 
gradients are established [40], [41] and [42]. This cellular effect may 
explain the paradoxical increase in BH4 in older hearts compared to 
young hearts. In older (11 months) mice a decreased cardiac GTPCH 
activity was found but it is in this period that BH4 is elevated compared 
to hearts of younger (<6 months) mice. 
While biopterin levels do not support the idea that BH4 or BH2 
permeates to plasma, these measures cannot discriminate between 
cell and cell interactions. We have shown that BH2 uptake by 
endothelial cells is a slow process and that conversion of BH2 to BH4 is 
effective when threshold concentrations have been reached [15]. Thus 
while this process may occur in young hearts, the distribution of BH2 in 
other cells is more probable to be more noticeable in old hearts that 
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have accumulated large amounts of BH2. As a consequence of this 
process an effective change in BH4-to-BH2 ratios are established. 
Others studies using newly generated cardiomyocyte-specific GTPCH 
transgenic hearts showed that significant increase (p<0.01) in non-
myocyte fraction of cells from cardiomyocyte GTPCH transgenic mice 
was found, although the most prominent accumulation of BH4 is seen 
in LV myocytes [40]. These transgenic hearts expressed a lower level 
of GTPCH, BH4 and BH2 which will attenuate this process. 
An intriguing aspect of this study is the demonstration that 
increased BH4 production in normal and healthy hearts is followed by 
increased accumulation of BH2 even in very young hearts. The most 
accepted mechanisms for the conversion of BH4 to BH2 are associated 
with increased levels of reactive species that react with BH4 to 
generate BH2 and/or changes in redox environment that decrease 
GTPCH activity and BH4 production [43], [44] and [45]. An oxidative 
mechanism however cannot fully explain the early changes in BH2 level 
as the chronic (genetic) increase in BH4 is expected to completely 
inhibit NOS-dependent superoxide production and therefore decreasing 
oxidant-mediated BH4 oxidation. Also the highest ascorbate to BH4 
ratio was found in young hearts. Although at a later time, a low ratio 
BH4-to-BH2 will most likely enhance superoxide production from eNOS 
by an uncoupling mechanism [46] which will accelerate the oxidation 
of BH4, the early mechanism explaining an increased BH2 production is 
not totally clear. 
One possible explanation for the increased oxidation of BH4 in 
young transgenic hearts could be linked to the facilitated oxidation of 
unbound protein-free BH4 that could increase superoxide 
concomitantly to eNOS-BH4 increasing NO production, and thereby 
producing peroxynitrite. Our studies trying to discern if NO production 
was increased in the transgenic hearts, however did not show direct 
evidence that this is the case. The EPR data suggests however the 
possibility that some increase in NO is initially reached, but rapidly 
inactivated through the reaction with oxymyoglobin (MbO2) to 
generate methemyoglobin and nitrate (k~5×107 M−1 s−1) [47]. There 
is also the possibility that peroxynitrite itself increases methemoglobin 
and nitrate levels upon reaction with MbO2. EPR analysis showed an 
marked increase in high spin porphyrin-Fe(III) signal (g~6) in the 
young transgenic hearts which indicates formation of metmyoglobin; 
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changes in nitrate levels are difficult to establish as nitrite background 
level is already very high in heart tissue. A role for peroxynitrite as the 
oxidant species increasing BH2, is unlikely since the g~6 signal 
decreases while BH2 continues to accumulate with age. 
An NO-independent mechanism that may explain the 
accelerated oxidation of BH4 in cardiomyocytes is via autoxidation 
reaction of BH4 generating superoxide which in the dismutation 
reaction generates hydrogen peroxide and via reaction with Fe(III)-
porphyrins. The reaction of BH4 as one-electron donors to Fe(III) 
porphyrins has been established on the basis of kinetic data analysis 
[48]. The rates of BH4 oxidation was shown to be a function of the 
redox potential of the protein with ferricytochrome c (Em=260 mV) 
being more favorable than other haemoproteins like catalase or 
horseradish peroxidase, which have a very low redox potential [48]. 
From these studies and relevant to cardiac cells, the reaction of BH4 
with metmyoglobin (Em~50 mV) [49] is also predicted to be much less 
favorable than hemoglobin and ferricytochrome c. The reaction of BH4 
with ferric-proteins like cytochrome c will form the one-electron 
oxidation product of BH4 (BH4-free radical) and the ferrous-protein. In 
solution i.e. protein-free BH4 radical at physiological pH levels will be 
found as deprotonated carbon-centered radical ∙BH4; pKa 5.2±0.1 [50]. 
The C4a electron rich carbon-centered BH4 radical rapidly reacts with 
oxygen to generate superoxide radical anion and/or BH4 peroxyl 
radical (BH4OO∙), which could oxidize another BH4 in the propagation 
reaction [51], with the generation of BH4-hydroperoxide intermediate 
[52]. The decomposition of the BH4-hydroperoxide generates BH2 and 
hydrogen peroxide [52] and [53]. The consequences of this 
mechanism are very significant. It indicates that in cardiomyocytes 
cells that are rich in cytochrome c, BH4 itself can be a driver of 
increased H2O2 formation through an accelerated oxidation of the 
unbound cofactor. 
The process considered above would explain the initial 
accelerated BH4 oxidation and BH2 formation in the heart of otherwise 
normal healthy animals. Following this event, it is possible to envision 
that the competition between BH4 and BH2 for the eNOS pterin-binding 
site will result in the uncoupling of l-arginine and NADPH oxidation 
catalyzed by eNOS, and increasing superoxide release from eNOS 
[46]. Through this mechanism the accumulation of BH2 will mediate 
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oxidative injury and may explain the observed changes in oxidative 
markers lipid peroxidation resulting in the formation of 4-HNE, loss of 
cytosolic aconitase activity and the observed GSH depletion. 
Importantly, these changes are paralleled by an accelerated loss of 
mitochondrial function in older hearts indicating the significance of the 
accumulated oxidant damage. 
Taken together our results indicate that paradoxically, 
increasing BH4 content in cardiomyocyte resulted in mitochondrial loss 
of function that is not associated with high NO fluxes but with changes 
in cardiomyocyte redox status. These redox-modifications are 
aggravated with age as NOS-uncoupling will be favored due to a 
greater accumulation of BH2 than BH4 in cardiomyocytes. Whether lack 
of benefits observed in short term oral treatment with high BH4 can be 
explained by similar mechanisms seems unlikely since BH4 levels 
reached in the heart are significantly lower than BH4 produced from 
GTPCH over-expression in cardiomyocytes, and more information 
would be necessary to better understand the mechanisms of 
cytotoxicity in supplementation. In conclusion, the present study 
indicates that a better understanding of the cellular factors affecting 
the stability of BH4 in different cellular milieu is essential to design 
better strategies to deliver BH4 and successfully adopt its use in the 
clinic. 
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Figure 1 Suppl. GTP cyclohydrolase I expression levels in the LV tissue from 
3- and 10 month old transgenic mice. Freshly obtained tissue was homogenized 
and proteins were resolved by PAGE-SDS. Values are Mean±SD n=4 samples. 
*p<0.05 
Table I. Aconitase activity in cytosolic and mitochondrial fractions obtained 
from 1, 3 and 10 month old heart overexpressing GTP cyclohydrolase. Enzyme 
activity was determined at 25ºC following the conversion of isocitrate to cis-aconitate 
as described in Materials and Methods. Values are Mean±S.D of n=3 except for 1 
month n=2. *p=0.05. 
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